Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Perspective Therapeutics (CATX) Non Operating Income (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Non Operating Income for 16 consecutive years, with -$7.6 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 379.14% to -$7.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.3 million through Sep 2025, up 48.51% year-over-year, with the annual reading at $10.5 million for FY2024, N/A changed from the prior year.
  • Non Operating Income hit -$7.6 million in Q4 2025 for Perspective Therapeutics, down from $1.9 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $3.7 million in Q1 2025 to a low of -$7.6 million in Q4 2025.
  • Historically, Non Operating Income has averaged $594736.8 across 5 years, with a median of $268000.0 in 2023.
  • Biggest five-year swings in Non Operating Income: skyrocketed 3000.0% in 2021 and later plummeted 379.14% in 2025.
  • Year by year, Non Operating Income stood at $31000.0 in 2021, then soared by 1709.68% to $561000.0 in 2022, then plummeted by 242.96% to -$802000.0 in 2023, then skyrocketed by 438.9% to $2.7 million in 2024, then tumbled by 379.14% to -$7.6 million in 2025.
  • Business Quant data shows Non Operating Income for CATX at -$7.6 million in Q4 2025, $1.9 million in Q3 2025, and $2.0 million in Q2 2025.